Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Clinical trial NCT06045247 · RECRUITING
Trial details
- NCT number
- NCT06045247
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-05
- Primary completion
- 2028-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.